Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China · Delayed Price · Currency is CNY 17.03
+1.07 (6.70%)
Jun 29, 2026, 3:04 PM CST
SHE:000739 Market Cap
SHE:000739 has a market cap or net worth of 19.17 billion as of June 29, 2026. Its market cap has increased by 18.23% in one year.
Market Cap
19.17B
Enterprise Value
17.10B
Revenue
9.50B
Ranking
n/a
PE Ratio
21.98
Stock Price
17.03
Market Cap Chart
Since January 2, 2001, SHE:000739's market cap has increased from 2.10B to 19.17B, an increase of 814.86%. That is a compound annual growth rate of 9.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 19.17B | 2.62% |
| Dec 31, 2025 | 18.68B | -0.80% |
| Dec 31, 2024 | 18.84B | 4.67% |
| Dec 29, 2023 | 18.00B | -28.65% |
| Dec 30, 2022 | 25.22B | -39.01% |
| Dec 31, 2021 | 41.35B | 50.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tasly Pharmaceutical Group | 19.78B |
| Guangdong Zhongsheng Pharmaceutical | 19.20B |
| Shanghai Haoyuan Chemexpress | 19.12B |
| Walvax Biotechnology | 18.66B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 18.52B |
| Chengdu Kanghong Pharmaceutical Group | 17.98B |
| Hybio Pharmaceutical | 17.46B |
| Dizal (Jiangsu) Pharmaceutical | 16.97B |